Mg0003 50088 — Washington D.C., District of Columbia

Mg0003 50088 is a clinical research site located in Washington D.C., District of Columbia, United States 20037.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Mg0003 50088 has participated in 1 clinical trials.

Therapeutic areas: Generalized Myasthenia Gravis.

Sponsors: UCB Biopharma SRL.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mg0003 50088?

Mg0003 50088 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mg0003 50088 conducted?

Mg0003 50088 has 1 clinical trials on record. Their work covers Generalized Myasthenia Gravis.

Is Mg0003 50088 accredited by Crixeo Health?

Mg0003 50088 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mg0003 50088?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.